EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseUmbrella Review

Lithium for Suicide Prevention: Umbrella Review and Meta-Analysis

Otávio de Lacquila Yano, Giuliana Perrotte, Taeho Greg Rhee, Beatriz Almeida Silva De Thomaz, Vitória Penido de Paula, Jonatas Magalhaes Santos, Guilherme Pimenta Roncete, Fernando S Goes, Euripedes Constantino Miguel, Orestes V Forlenza, Michael H Bloch, Gustavo Turecki und 3 weitere

American Journal of Psychiatry · 18.11.2026

DOI: 10.1176/appi.ajp.20260631 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Psychiatry, online erschienen am 18.11.2026. Verfasst von Otávio de Lacquila Yano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (IPq-HCFMUSP), São Paulo, Brazil. Die Arbeit nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Lithium has anchored suicide-prevention guidelines for five decades, yet quantitative syntheses of the randomized evidence have produced divergent estimates. The authors evaluated the contemporary randomized evidence on lithium for suicide-related outcomes in patients with psychiatric disorders. METHODS: Five databases were searched from inception to April 6, 2026, for systematic reviews with meta-analyses of randomized trials comparing lithium with placebo, treatment as usual, or active comparators; all eligible trials were re-extracted, with an updated six-source primary-trial search from January 2024. Prespecified outcomes were completed suicide, suicide attempt, deliberate self-harm, all-cause mortality, composite suicide-related events, and treatment discontinuation. The primary estimator was the Mantel-Haenszel odds ratio without continuity correction, and certainty of evidence was rated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. RESULTS: Ten systematic reviews, one reanalysis, and 20 trial publications (22 strata; 3,675 participants) were included. For completed suicide (11 informative comparisons, 2,292 participants; six events with lithium vs. 16 with comparators), the pooled estimate favored lithium but included the null (odds ratio [OR]=0.39, 95% CI=0.15, 1.00; I²=0%). A Peto sensitivity estimate reached statistical significance (OR=0.42, 95% CI=0.18, 0.98), whereas excluding the most influential comparison attenuated the estimate (OR=0.43, 95% CI=0.13, 1.40). In exploratory subgroup analysis, the signal concentrated in trials enrolling mixed mood-disorder populations (four trials; OR=0.25, 95% CI=0.07, 0.90). Treatment discontinuation favored lithium over placebo but active comparators over lithium. No significant effects emerged for suicide attempt, deliberate self-harm, all-cause mortality, or composite suicide-related events. GRADE certainty was low to very low. CONCLUSIONS: Current evidence indicates greater uncertainty than suggested by earlier syntheses, with a sparse completed-suicide signal that was estimator-sensitive and with no consistent evidence across related outcomes. Lithium remains a treatment option when clinically indicated, but adequately powered pragmatic trials that prespecify suicidal behavior and balance clinical contact between arms are needed.

Schlagwörter

Stichwörter der Autor:innen

Bipolar DisorderLithiumMeta-AnalysisMood DisordersRandomized Controlled TrialsSuicide

Autor:innen und Institutionen

  • Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (IPq-HCFMUSP), São Paulo, Brazil.
  • Program for Education, Research, and Care in Treatment-Resistant Depression, Self-Injury, and Suicidality, IPq-HCFMUSP, São Paulo, Brazil.
  • Department of Psychiatry, Yale University, New Haven, CT.
  • Departamento de Medicina Preventiva, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Center of Research and Innovation in Mental Health, São Paulo, Brazil.
  • Stanley and Elizabeth Star Precision Medicine Center of Excellence in Mood Disorders, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore.

ORCID-Profile: Rodolfo Furlan Damiano

Zitieren

APA

Yano, O. L., Perrotte, G., Rhee, T. G., De Thomaz, B. A. S., Penido de Paula, V., Magalhaes Santos, J., Roncete, G. P., Goes, F. S., Miguel, E. C., Forlenza, O. V., Bloch, M. H., Turecki, G., Farhat, L. C., Zarate, C. A., & Damiano, R. F. (2026). Lithium for Suicide Prevention: Umbrella Review and Meta-Analysis. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20260631

Vancouver

Yano OL, Perrotte G, Rhee TG, De Thomaz BAS, Penido de Paula V, Magalhaes Santos J, et al. Lithium for Suicide Prevention: Umbrella Review and Meta-Analysis. American Journal of Psychiatry. 2026. doi:10.1176/appi.ajp.20260631

BibTeX
@article{Yano2026,
  author = {Yano, Otávio de Lacquila and Perrotte, Giuliana and Rhee, Taeho Greg and De Thomaz, Beatriz Almeida Silva and Penido de Paula, Vitória and Magalhaes Santos, Jonatas and Roncete, Guilherme Pimenta and Goes, Fernando S and Miguel, Euripedes Constantino and Forlenza, Orestes V and Bloch, Michael H and Turecki, Gustavo and Farhat, Luis C and Zarate, Carlos A and Damiano, Rodolfo Furlan},
  title = {Lithium for Suicide Prevention: Umbrella Review and Meta-Analysis},
  journal = {American Journal of Psychiatry},
  year = {2026},
  doi = {10.1176/appi.ajp.20260631}
}
Kostenlos starten →